{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:21:09Z","timestamp":1776223269054,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002002","name":"Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006479","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018878","name":"OrbusNeich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ahj.2017.11.011","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:17:59Z","timestamp":1512519479000},"page":"142-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study"],"prefix":"10.1016","volume":"197","author":[{"given":"Bj\u00f6rn","family":"Redfors","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"G\u00e9n\u00e9reux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Witzenbichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"McAndrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ahj.2017.11.011_bb0005","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ahj.2017.11.011_bb0010","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2010.02.009","article-title":"Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study","volume":"55","author":"Mehilli","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2017.11.011_bb0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4244\/EIJV6I6A117","article-title":"Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial","volume":"6","author":"Wiemer","year":"2011","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.ahj.2017.11.011_bb0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2011.11.047","article-title":"Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation","volume":"59","author":"Song","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2017.11.011_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1540-8183.2012.00769.x","article-title":"One-year results of the CRISTAL trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents","volume":"25","author":"Chevalier","year":"2012","journal-title":"J Interv Cardiol"},{"issue":"9865","key":"10.1016\/j.ahj.2017.11.011_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ahj.2017.11.011_bb0035","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2017.11.011_bb0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcin.2013.08.011","article-title":"A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial","volume":"7","author":"Xu","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ahj.2017.11.011_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"9892","key":"10.1016\/j.ahj.2017.11.011_bb0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ahj.2017.11.011_bb0055","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ahj.2017.11.011_bb0060","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ahj.2017.11.011_bb0065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4244\/EIJV9I7A132","article-title":"Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials","volume":"9","author":"Byrne","year":"2013","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.ahj.2017.11.011_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"issue":"9591","key":"10.1016\/j.ahj.2017.11.011_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ahj.2017.11.011_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ahj.2017.11.011_bb0085","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2005.10.078","article-title":"A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial","volume":"47","author":"Alfonso","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2017.11.011_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amjcard.2008.09.107","article-title":"Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents","volume":"103","author":"Steinberg","year":"2009","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.ahj.2017.11.011_bb0095","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1161\/01.CIR.0000130173.63105.4E","article-title":"Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2017.11.011_bb0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ahj.2009.06.004","article-title":"Optical coherence tomography patterns of stent restenosis","volume":"158","author":"Gonzalo","year":"2009","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.ahj.2017.11.011_bb0105","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","article-title":"Efficacy and safety of dual antiplatelet therapy after complex PCI","volume":"68","author":"Giustino","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2017.11.011_bb0110","first-page":"26","article-title":"Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: insights from the ADAPT-DES study","volume":"89","author":"Genereux","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ahj.2017.11.011_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.113.003942","article-title":"Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study","volume":"129","author":"Witzenbichler","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2017.11.011_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCINTERVENTIONS.110.940320","article-title":"Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis","volume":"4","author":"Kang","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.11.011_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2014.10.139","article-title":"Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis","volume":"178","author":"Alfonso","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2017.11.011_bb0130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jtcvs.2012.01.061","volume":"143","author":"Coronary Revascularization Writing G","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.ahj.2017.11.011_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14779072.2017.1284588","article-title":"Treatment of coronary artery in-stent restenosis","volume":"15","author":"Kokkinidis","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"13","key":"10.1016\/j.ahj.2017.11.011_bb0140","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4244\/EIJV11I13A287","article-title":"A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold","volume":"11","author":"Jamshidi","year":"2016","journal-title":"EuroIntervention"},{"issue":"20","key":"10.1016\/j.ahj.2017.11.011_bb0145","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2017.11.011_bb0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13239-012-0109-3","article-title":"Reducing in-stent restenosis through novel stent flow field augmentation","volume":"3","author":"Murphy","year":"2012","journal-title":"Cardiovasc Eng Technol"},{"issue":"7","key":"10.1016\/j.ahj.2017.11.011_bb0155","first-page":"E143","article-title":"Rotational atherectomy combined with bioresorbable vascular scaffold implantation: a feasible approach for recurrent in-stent restenosis when other therapies failed","volume":"27","author":"Pereira-da-Silva","year":"2015","journal-title":"J Invasive Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317303782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317303782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:30Z","timestamp":1757570430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"alternative-id":["S0002870317303782"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.11.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}